Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool

被引:73
作者
Hanenberg, H
Batish, SD
Pollok, KE
Vieten, L
Verlander, PC
Leurs, C
Cooper, RJ
Göttsche, K
Haneline, L
Clapp, DW
Lobitz, S
Williams, DA
Auerbachc, AD
机构
[1] Univ Dusseldorf, Ctr Med, Childrens Hosp, Dept Pediat Hematol & Oncol, D-40225 Dusseldorf, Germany
[2] Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA
[3] Rockefeller Univ, Lab Human Genet & Hematol, New York, NY USA
[4] Howard Hughes Med Inst, Indiana Sch Med, Indianapolis, IN USA
关键词
D O I
10.1016/S0301-472X(02)00782-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The aim of this study was to develop a rapid laboratory procedure that is capable of subtyping Fanconi anemia (FA) complementation groups FA-A, FA-C, FA-G, and FA-non-ACG patients from a small amount of peripheral blood. Materials and Methods. For this test, primary peripheral blood-derived FAT cells were transduced with oncoretroviral vectors that expressed FANCA, FANCC, or FANCG cDNA. We achieved a high efficiency of gene transfer into primary FA T cells by using the fibronectin fragment CH296 during transduction. Transduced cells were analyzed for correction of the characteristic DNA cross-linker hypersensitivity by, cell survival or by metaphase analyses. Results. Retroviral vectors containing the cDNA for FA-A, FA-C, and FA-G, the most frequent complementation groups in North America, allowed rapid identification of the defective gene by complementation of primary T cells from 12 FA patients. Conclusion. Phenotypic correction of FA T cells using retroviral vectors can be used successfully to determine the FA complementation group immediately after diagnosis of the disease. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:410 / 420
页数:11
相关论文
共 69 条
  • [1] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [2] Auerbach AD, 2001, AM J HUM GENET, V69, P612
  • [3] Auerbach AD, 2000, BLOOD, V96, p229A
  • [4] AUERBACH AD, 1989, BLOOD, V73, P391
  • [5] AUERBACH AD, 1993, EXP HEMATOL, V21, P731
  • [6] AUERBACH AD, 1994, CURRENT PROTOCOLS HU
  • [7] Auerbach AD, 1989, FANCONI ANEMIA CLIN, P213
  • [8] AUERBACH AD, 2002, IN PRESS GENETIC BAS
  • [9] Auerbach Arleen D., 1997, Current Opinion in Pediatrics, V9, P600, DOI 10.1097/00008480-199712000-00010
  • [10] Is Fanconi anemia caused by a defect in the processing of DNA damage?
    Buchwald, M
    Moustacchi, E
    [J]. MUTATION RESEARCH-DNA REPAIR, 1998, 408 (02): : 75 - 90